Reckitt Benckiser Inc recalls Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Si
Recalled May 8, 2013 · FDA recall D-310-2013 · Reckitt Benckiser
Hazard
Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine. · FDA Class III
Units
27,718 cases 16 count and 7,551 cases 576 count
Sold at
Nationwide
Description
Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.
Product
Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054
Manufacturer(s)
Reckitt Benckiser Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →